Bupropion Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 70518-3790

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 70518-3790). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Label for Bupropion Hydrochloride Extended-Release (XL) 300 mg tablet. The label indicates a quantity of 30 tablets, with the product repackaged by RemedyRepack Inc. The manufacturer is ScieGen Pharmaceuticals, Inc. The label includes an NDC number 70518-3790-00 and storage directions to keep at 20-25°C with allowed excursions.*

FDA Label Image

Bupropion Hydrochloride Chemical Structure (Bupropion Hydrochloride Sr 1)

Chemical structure of bupropion hydrochloride showing a chlorophenyl ring attached to a ketone and a tert-butylamino group with the hydrochloride salt indicated.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.